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Purpose of review: Publicly funded health care systems are increasingly confronted with fiscal and demographic
challenges and face pressure to constrain resource use without impacting clinical outcomes.
Findings: Clinicians routinely make decisions in the care of their patients that use finite health care resources.
Aligning the goal of caring for their patients with ensuring that effective interventions are available for patients
who are most likely to benefit is critical to sustaining the publicly funded health care system.
Implications: Balancing the needs of patients with health care prioritization will require changes to be made across
the health care system. Incorporating costs and value for money when caring for patients and making decisions
will play an important role in efficiency and value in the health system.
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Objectif: Les systèmes publics de santé sont de plus en plus confrontés aux défis fiscaux et démographiques, et se
voient contraints de limiter l’utilisation des ressources sans toutefois compromettre les résultats cliniques.
Résultats: Les cliniciens prennent régulièrement des décisions relatives aux soins aux patients qui requièrent des
ressources limitées en soins de santé. Poursuivre l’objectif de prodiguer les soins aux patients, tout en assurant une
offre d’interventions efficaces à ceux qui sont les plus susceptibles d’en bénéficier, est essentiel au maintien du
système public de santé.
Implications: Trouver l’équilibre entre les besoins des patients et l’ordre des priorités des soins de santé requerra
que soient apportés des changements dans le système de santé. L’intégration des coûts et de l’optimisation des
ressources lors de la prestation des soins aux patients et de la prise de décisions jouera un rôle important dans
l’efficacité et la valeur du système de santé.Why is this report important
Publicly funded health care systems face increasing pressure
to constrain resource use without impacting health care
services. Clinicians are a key member of the health care
team, being responsible for ordering tests and treatments.What are the key messages
Most decisions regarding clinical care should be made after
consideration of potential benefits and costs, incorporating
the notion of value for money. Health care prioritization* Correspondence: Braden.manns@albertahealthservices.ca
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unless otherwise stated.should be a duty for all involved in the care of patients, and
active clinician engagement is required.Introduction
Confronted with fiscal and demographic challenges [1],
publicly funded health care systems face increasing pressure
to constrain resource use without impacting health care
services. As less than one half of one percent of the nation’s
population [2], clinicians, be it a nephrologist or an allied
health professional caring for someone with kidney disease,
determine how over 10% of the gross domestic product is
spent [3], making clinical decisions “purchasing decisions”.
These decisions should be made within the context of
competing uses of finite resources to ensure that the most
effective interventions are available for the patients who arel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Barnieh et al. Canadian Journal of Kidney Health and Disease 2014, 1:27 Page 2 of 5
http://www.cjkhd.org/content/1/1/27most likely to benefit [4]. Health care managers indirectly
determine how to allocate scarce health care resources, by
determining what tests and treatments will be made avail-
able. However, prioritizing health care resources should not
be seen as the sole responsibility of managers and decision
makers, and to be successful in maximizing population
health, active engagement of clinicians, who directly
allocate health care resources through ordering of tests and
treatments, is required.
The issue of health care prioritization is particularly rele-
vant for clinicians working with patients with kidney failure
since they are often cared for in the context of provincial
renal programs, who determine how allocated resources
are best used to care for all patients with end-stage renal
disease (ESRD). In this context, funds or resources spent
on one patient are no longer be available for other patients
with kidney failure in the renal program. Herein, we discuss
the challenges that clinicians face in participating in health
care prioritization and outline how they can incorporate
the cost of health care and the concept of value for money
in their decision making.
Review
Clinicians (the providers) receive extensive training in
how to investigate, diagnose, and manage patients, but
receive little training in health care priority setting. On the
other hand, health care systems and administrators (the
payers) focus almost exclusively on priority setting, outlin-
ing overall objectives for the system. Their mandate
stresses staying within allocated budgets, and though they
have a lot of responsibility, they typically lack the power to
affect the decisions made on the front-lines by clinicians.
While most private enterprises are able to direct the
performance of their employees through incentives to
ensure their goals are met, the Canadian health care
system is not a private enterprise and most nephrologists in
Canada are independent practitioners. Clinicians’ are broadly
motivated by one of three things: the benefit to the patient
(i.e. successful transplant), social good (i.e. promoting aTable 1 Proposed strategies to consider costs and the concep
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Continuing medical education should educate clinicians on
how to incorporate cost and “value for money” in clinical practice,
particularly for management of common clinical conditions
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phealthy lifestyle), and/or personal interests and desires (i.e.
target income) [5]. Clinicians are accountable to their pa-
tients by ensuring that the care they provide serves the best
interest of their patients. However, they are also accountable
to the greater health care system and by extension to other
patients, for their spending patterns. Clinicians have two
fundamental responsibilities: to “consider the well-being of
the patient” and to “consider the well-being of society in
matters affecting health” [6]. Dealing with a potential lack of
alignment between the priorities of clinicians and the health
system is critical to addressing the common objectives of
both parties: providing high quality health care and improv-
ing outcomes for all, maximizing beneficence and justice.
Suggestions for incorporating cost and value for money
within health care
To ensure health system sustainability, changes are needed,
both for clinicians and for the broader health system
(Table 1).
Suggestions for clinicians
Firstly, the way future clinicians are educated needs to
be re-evaluated. Medical students and residents need to
be taught how to reasonably incorporate the notion of
“value for money” into their daily care for patients. An
understanding of basic principles of health economics, and
health care prioritization is required—fundamental skills
that should be part of undergraduate and continuing
medical education. While being a health care manager is a
core competency within CanMEDS, even the basics of
how to incorporate the notion of cost into clinical
decision-making is not emphasized during formal education
of undergraduate students or residents and is not empha-
sized during continuing medical education [8]. Medical
students and residents should be taught not only how to
integrate cost into their practice, but the principles of
economic evaluations, including how to read and interpret
economics evaluations for common treatments in their prac-
tice area [9]. Clinicians make value-based decisions aboutt of value for money when caring for patients
xample
ducating clinicians to promote home dialysis options, given the
ost savings and equal or better outcomes for patients that are eligible
outine management of abnormalities of mineral metabolism with
xpensive medications with an incomplete evidence base such as
on-calcium based phosphate binders and cinacalcet
uring the development of the timing of dialysis initiation guidelines
y the Canadian Society of Nephrology [7], resource use was incorporated
s a secondary outcome
eveloping clinical practice guidelines to increase the use of home
erapies
upport knowledge dissemination activities related to existing clinical
ractice guidelines
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hospital or intensive care unit—and need to apply this same
skill set to other health care resources [10]. A clinician with
the required skill set to participate in priority setting in an
informed way, is more likely to participate, benefiting the
patient and the system.
Although rarely discussed during training, it should be
made clearer that in a cash strapped system, resources may
be redeployed to fund more effective interventions. This is
particularly true if the effectiveness of the intervention is
marginal at best, or has only been shown to impact nonclini-
cal endpoints [11], in other words, when significant clinical
uncertainty exists. Clinicians should not feel compelled to
routinely offer such therapies or tests, particularly when they
are notably more expensive than the current standard of
care. Clinicians need to begin to routinely consider cost and
“value for money” in clinical practice, particularly when mak-
ing management decisions for situations where several po-
tential strategies exist.
Value for money is usually estimated using economic
evaluations, which weigh the resources used (costs) with
health outcomes (benefits) of competing programs. This is
central to health economics and rests on the principles of
scarcity and choice [4]. Given resource scarcity, choices
must be made about what health programs or services to
provide and which to forgo – also known as “opportunity
cost”. For example, when developing the budget for a
renal program, money may be directed to more aggressive
monitoring of vascular accesses, or to hire additional
personnel to expedite the workup of potential kidney
donors. If the program chose to hire additional personnel
to expedite a donor’s transplant workup, the opportunity
cost of this would be the clinical benefits that patients
might have received had more aggressive monitoring of
vascular access been implemented. When making a deci-
sion in health economics, one must ensure that the value
of a treatment is greater than the “opportunity cost” (i.e.
the health benefits) of other programs that are being con-
sidered. Since clinicians working in publicly funded health
care systems spend limited tax-payer dollars, they should
consider the resource implications of each treatment, in
addition to the impact on health outcomes, by applying
the above principles.
While physicians might feel uncomfortable consider-
ing health care costs in all situations, for instance when
a patient’s life is in immediate risk, in most situations,
considering the opportunity cost of the treatment under
consideration is feasible and important. Indeed, if costs
were integrated when developing clinical practice guide-
lines, incorporating the consideration of cost into usual
clinician practice would become easier. While cost
constraint is not the explicit goal of the Choosing Wisely
campaign, this is an example of an initiative (currently
being undertaken within nephrology in Canada by theCanadian Society of Nephrology) which is meant to help
clinicians and patients engage in conversations about
unnecessary tests, treatments and procedures in order to
make smart and effective choices in care [12].
Lanthanum carbonate is one example of the issue faced by
clinicians when costs are not incorporated when developing
clinical practice guidelines. Lanthanum carbonate was
reviewed for consideration of funding by the Canadian
Common Drug Review (CDR) [13] in 2008. Eight RCTs in a
total of 2,646 patients, ranging in duration from four weeks
to two years, met the inclusion criteria for the systematic
review. In these studies, lanthanum was not shown to im-
prove quality of life, or reduce rates of bone fracture or car-
diovascular complications. Acknowledging that lanthanum
has been shown to cause fewer episodes of hypercalcemia
than calcium-based phosphate binders, given a cost per day
of lanthanum between $6.18 to $12.23, the CDR did not
recommend funding for lanthanum. However, this decision
is not consistent with contemporary clinical practice guide-
lines for the management of bone and mineral metabolism
abnormalities in kidney disease which recommend the use
of non-calcium containing phosphate binders in several
clinical scenarios, including as first-line therapy [14]. With-
out incorporating the impact of treatment on costs in the
guidelines, it is difficult for clinicians to incorporate the
notion of “value for money” into their routine practice, and
inevitably leads to conflict between prescribers and health
system funders.
As leaders within the health care system, though clini-
cians may be reluctant to incorporate the consideration of
cost in their daily care, their role in allocating scarce
resources cannot be avoided. Indeed, since one of the roles
of publicly funded health care is to maximize health gains
within a restricted budget, limiting expensive therapies to
those who can benefit most seems a reasonable and equit-
able approach. Clinician leaders can be engaged to act on
behalf of other clinicians when establishing health policy,
including determining what new programs to offer, particu-
larly in nephrology, given that care of patients with kidney
failure is often funded within provincial renal programs.
Within such programs, modifying and adhering to clinician-
developed clinical practice guidelines that take cost into
account could help ease the tension between clinician’s
clinical decision making and health system objectives.
Suggestions for the broader health system
Table 2 highlights ways in which cost can be considered
within the health care system.
Clinicians are not the only group that needs to be targeted
to offload stress in the system; change by other health care
players could make it easier for physicians to consider value
for money. For instance, to achieve a sustainable health care
system, decision makers need to systematically consider
information on effectiveness and costs when determining
Table 2 Proposed changes to the broader health care system to increase consideration of costs and the concept of
value for money when caring for patients
Proposed change Who can make the change
Incorporate health economics and consideration of cost into medical education as a professional ethic Royal College of Physicians and
Surgeons of Canada
Medical schools
Similar to the system that currently exists for assessing new medications [13], when assessing new tests or
technologies for funding, health systems should systematically review evidence on the impact on outcomes
and costs, providing preferential access to those tests and technologies offering best value for money
(i.e. better outcomes for less money)
Provincial health systems
Federal health ministry
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is entrenched within the assessment of new drugs across
Canada [13], it is not yet systematically applied to other
non-drug interventions before they are made available
across Canada. To assist with larger and more complex
health programs, the process of program budgeting and
marginal analysis (PBMA) is used for priority setting, and
may help align the goals of doctors and managers by con-
tinually assessing and re-assessing marginal effectiveness of
available programs [15]. PBMA examines programs – for
either the same or different groups of patients - that are ei-
ther close to being funded, or of limited value where the
program is considered for retraction, assessing whether the
benefits of the new program added outweigh the benefits
an existing program that costs a similar amount.
Another issue worth considering is that most physicians
in Canada are still remunerated on a fee-for-service basis,
which is appropriate in areas where the health care system
has high volume needs, such as vaccination and preventive
care, but may be less appropriate for some areas within
nephrology (for instance, payment for caring for patients
with ESRD on dialysis). Though physician remuneration is
an important issue, governments appear unwilling to deal
with this highly contentious issue. Alternative mechanisms
to pay physicians, without altering their employment
status as an independent practitioner, exist. In England,
only about 10 to 15% of physician salaries are fee-for-
service, with the remainder based on capitation and
targeted payments [4]. Designing a remuneration system
which is consistent with the objectives of the health care
system, but provides physicians independence all while
offering acceptable incentives to reward priority activities
is, therefore, challenging, but feasible.
Conclusions
Balancing the needs of patients with health care
prioritization may be one of the most complex and
challenging tasks facing today’s clinician, but one that
needs to be urgently undertaken if publicly funded health
care is to be sustained. As clinicians play an important
role in efficiency and value in the health system, creatingsuccessful partnerships between clinicians and health care
managers is crucial to aligning the goals of both parties
and cultures.
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